(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1350976 6480464 epigallocatechin gallate inhibits the reaction [Ozone results in decreased secretion of SLPI protein] CTD PMID:22496898 (-)-epigallocatechin 3-gallate increases expression ISO RGD:1350976 6480464 epigallocatechin gallate results in increased expression of SLPI mRNA CTD PMID:22496898 1,2-dichloroethane increases expression ISO RGD:1551752 6480464 ethylene dichloride results in increased expression of SLPI mRNA CTD PMID:28960355 1-chloro-2,4-dinitrobenzene affects expression ISO RGD:1551752 6480464 Dinitrochlorobenzene affects the expression of SLPI mRNA CTD PMID:22302311 17alpha-ethynylestradiol multiple interactions ISO RGD:1551752 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLPI mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of SLPI mRNA CTD PMID:15834898 , PMID:17557909 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of SLPI mRNA CTD PMID:17010207 17beta-estradiol increases expression ISO RGD:1350976 6480464 Estradiol results in increased expression of SLPI mRNA CTD PMID:19619570 17beta-estradiol multiple interactions ISO RGD:1350976 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of SLPI mRNA, [Estradiol co-treated with TGFB1 protein] results in decreased expression of SLPI mRNA CTD PMID:19619570 , PMID:30165855 17beta-estradiol decreases expression ISO RGD:1350976 6480464 Estradiol results in decreased expression of SLPI mRNA CTD PMID:23019147 , PMID:31614463 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1551752 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLPI mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLPI mRNA CTD PMID:33387578 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1551752 6480464 Tetrachlorodibenzodioxin affects the expression of SLPI mRNA CTD PMID:18343893 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLPI mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1350976 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLPI mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1350976 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of SLPI mRNA CTD PMID:19619570 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO RGD:1551752 6480464 2 more ... CTD PMID:18343893 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO RGD:1551752 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of SLPI mRNA] CTD PMID:18200517 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:1551752 6480464 Trinitrobenzenesulfonic Acid results in increased expression of SLPI mRNA CTD PMID:18200517 2,4-diaminotoluene increases expression ISO RGD:1551752 6480464 2, 4-diaminotoluene results in increased expression of SLPI mRNA CTD PMID:20713471 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1551752 6480464 tetrabromobisphenol A results in increased expression of SLPI mRNA CTD PMID:25172293 3,3',5-triiodo-L-thyronine increases expression ISO RGD:1350976 6480464 Triiodothyronine results in increased expression of SLPI mRNA CTD PMID:32816093 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1551752 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of SLPI mRNA CTD PMID:16054899 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of SLPI mRNA CTD PMID:21346803 4-aminosalicylic acid increases expression ISO RGD:1350976 6480464 Aminosalicylic Acid results in increased expression of SLPI mRNA CTD PMID:32816093 4-hydroxyphenyl retinamide decreases expression ISO RGD:1551752 6480464 Fenretinide results in decreased expression of SLPI mRNA CTD PMID:28973697 4-nitrophenol decreases expression ISO RGD:1551752 6480464 4-nitrophenol results in decreased expression of SLPI mRNA CTD PMID:34673133 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SLPI mRNA CTD PMID:24780913 acetylsalicylic acid decreases expression ISO RGD:1350976 6480464 Aspirin results in decreased expression of SLPI mRNA CTD PMID:15928584 acetylsalicylic acid increases expression ISO RGD:1350976 6480464 Aspirin results in increased expression of SLPI mRNA CTD PMID:32816093 acrylamide increases expression ISO RGD:1551752 6480464 Acrylamide results in increased expression of SLPI mRNA CTD PMID:30807115 acyclovir increases expression ISO RGD:1350976 6480464 Acyclovir results in increased expression of SLPI mRNA CTD PMID:32816093 aflatoxin B1 increases expression ISO RGD:1551752 6480464 Aflatoxin B1 results in increased expression of SLPI mRNA CTD PMID:19770486 alatrofloxacin increases expression ISO RGD:1350976 6480464 alatrofloxacin results in increased expression of SLPI mRNA CTD PMID:32816093 albuterol decreases expression ISO RGD:1350976 6480464 Albuterol results in decreased expression of SLPI mRNA CTD PMID:32816093 all-trans-retinoic acid increases expression ISO RGD:1350976 6480464 Tretinoin results in increased expression of SLPI mRNA CTD PMID:33167477 amikacin increases expression ISO RGD:1350976 6480464 Amikacin results in increased expression of SLPI mRNA CTD PMID:32816093 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLPI mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of SLPI mRNA CTD PMID:30779732 arsane decreases expression ISO RGD:1551752 6480464 Arsenic results in decreased expression of SLPI mRNA CTD PMID:19654921 arsane multiple interactions ISO RGD:1350976 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SLPI mRNA CTD PMID:32525701 arsenic atom decreases expression ISO RGD:1551752 6480464 Arsenic results in decreased expression of SLPI mRNA CTD PMID:19654921 arsenic atom multiple interactions ISO RGD:1350976 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SLPI mRNA CTD PMID:32525701 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of SLPI gene CTD PMID:28931070 atropine increases expression ISO RGD:1350976 6480464 Atropine results in increased expression of SLPI mRNA CTD PMID:32816093 benzatropine increases expression ISO RGD:1350976 6480464 Benztropine results in increased expression of SLPI mRNA CTD PMID:32816093 benzene increases expression ISO RGD:1551752 6480464 Benzene results in increased expression of SLPI mRNA CTD PMID:34624356 benzo[a]pyrene increases expression ISO RGD:1551752 6480464 Benzo(a)pyrene results in increased expression of SLPI mRNA CTD PMID:20127859 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLPI mRNA CTD PMID:18180321 bisphenol A increases methylation ISO RGD:1551752 6480464 bisphenol A results in increased methylation of SLPI promoter CTD PMID:27312807 bleomycin A2 increases expression ISO RGD:1551752 6480464 Bleomycin results in increased expression of SLPI mRNA, Bleomycin results in increased expression of SLPI protein CTD PMID:26345256 , PMID:30825431 bleomycin A2 multiple interactions ISO RGD:1551752 6480464 Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of SLPI mRNA], lenabasum inhibits the reaction [Bleomycin results in increased expression of SLPI mRNA] CTD PMID:30825431 bromfenac increases expression ISO RGD:1350976 6480464 bromfenac results in increased expression of SLPI mRNA CTD PMID:32816093 butane-2,3-dione affects expression ISO RGD:1350976 6480464 Diacetyl affects the expression of SLPI mRNA CTD PMID:31381966 butane-2,3-dione increases secretion ISO RGD:1350976 6480464 Diacetyl results in increased secretion of SLPI protein CTD PMID:31381966 C60 fullerene increases expression ISO RGD:1551752 6480464 fullerene C60 results in increased expression of SLPI mRNA CTD PMID:20064541 calcitriol increases expression ISO RGD:1350976 6480464 Calcitriol results in increased expression of SLPI mRNA CTD PMID:26485663 cannabidiol multiple interactions ISO RGD:1551752 6480464 Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of SLPI mRNA] CTD PMID:30825431 carbon nanotube increases expression ISO RGD:1551752 6480464 Nanotubes more ... CTD PMID:25554681 carmustine affects response to substance ISO RGD:1350976 6480464 SLPI mRNA affects the susceptibility to Carmustine CTD PMID:16365179 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of SLPI mRNA CTD PMID:18500788 chlordecone increases expression ISO RGD:1551752 6480464 Chlordecone results in increased expression of SLPI mRNA CTD PMID:33711761 cisplatin affects response to substance ISO RGD:1350976 6480464 SLPI protein affects the susceptibility to Cisplatin CTD PMID:16217747 cisplatin decreases expression ISO RGD:1350976 6480464 Cisplatin results in decreased expression of SLPI mRNA CTD PMID:27392435 clavulanic acid increases expression ISO RGD:1350976 6480464 Clavulanic Acid results in increased expression of SLPI mRNA CTD PMID:32816093 cobalt dichloride increases expression ISO RGD:1350976 6480464 cobaltous chloride results in increased expression of SLPI mRNA CTD PMID:23052192 copper atom multiple interactions ISO RGD:1350976 6480464 [NSC 689534 binds to Copper] which results in increased expression of SLPI mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1350976 6480464 [NSC 689534 binds to Copper] which results in increased expression of SLPI mRNA CTD PMID:20971185 crocidolite asbestos increases expression ISO RGD:1551752 6480464 Asbestos, Crocidolite results in increased expression of SLPI mRNA CTD PMID:23917077 crocidolite asbestos decreases expression ISO RGD:1350976 6480464 Asbestos, Crocidolite results in decreased expression of SLPI mRNA CTD PMID:24160326 curcumin multiple interactions ISO RGD:1551752 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of SLPI mRNA] CTD PMID:18200517 cyclophosphamide decreases expression ISO RGD:1551752 6480464 Cyclophosphamide results in decreased expression of SLPI mRNA CTD PMID:15331540 cyclosporin A decreases expression ISO RGD:1350976 6480464 Cyclosporine results in decreased expression of SLPI mRNA CTD PMID:20106945 , PMID:27989131 desferrioxamine B decreases expression ISO RGD:1350976 6480464 Deferoxamine results in decreased expression of SLPI mRNA CTD PMID:32816093 dexamethasone multiple interactions ISO RGD:1551752 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of SLPI mRNA CTD PMID:16054899 dichlorine increases expression ISO RGD:1551752 6480464 Chlorine results in increased expression of SLPI mRNA CTD PMID:30189237 diclofenac increases expression ISO RGD:1350976 6480464 Diclofenac results in increased expression of SLPI mRNA CTD PMID:32816093 didanosine increases expression ISO RGD:1350976 6480464 Didanosine results in increased expression of SLPI mRNA CTD PMID:32816093 diethylstilbestrol increases expression ISO RGD:1551752 6480464 Diethylstilbestrol results in increased expression of SLPI mRNA CTD PMID:15171707 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of SLPI mRNA CTD PMID:17010207 dioxygen multiple interactions ISO RGD:1551752 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLPI mRNA CTD PMID:30529165 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of SLPI mRNA CTD PMID:33729688 diphenhydramine increases expression ISO RGD:1350976 6480464 Diphenhydramine results in increased expression of SLPI mRNA CTD PMID:32816093 diuron increases expression EXP 6480464 Diuron metabolite results in increased expression of SLPI mRNA CTD PMID:24172598 doxorubicin decreases expression ISO RGD:1350976 6480464 Doxorubicin results in decreased expression of SLPI mRNA CTD PMID:29803840 entacapone decreases expression ISO RGD:1350976 6480464 entacapone results in decreased expression of SLPI mRNA CTD PMID:32816093 esmolol increases expression ISO RGD:1350976 6480464 esmolol results in increased expression of SLPI mRNA CTD PMID:32816093 ethambutol increases expression ISO RGD:1350976 6480464 Ethambutol results in increased expression of SLPI mRNA CTD PMID:32816093 ethanol multiple interactions ISO RGD:1551752 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of SLPI mRNA CTD PMID:30517762 etodolac increases expression ISO RGD:1350976 6480464 Etodolac results in increased expression of SLPI mRNA CTD PMID:32816093 ferric oxide multiple interactions ISO RGD:1551752 6480464 [Magnetite Nanoparticles co-treated with ferric oxide] results in increased expression of SLPI mRNA CTD PMID:20540983 Fexofenadine hydrochloride increases expression ISO RGD:1350976 6480464 fexofenadine results in increased expression of SLPI mRNA CTD PMID:32816093 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of SLPI mRNA CTD PMID:18035473 fludrocortisone increases expression ISO RGD:1350976 6480464 Fludrocortisone results in increased expression of SLPI mRNA CTD PMID:32816093 flutamide increases expression ISO RGD:1350976 6480464 Flutamide results in increased expression of SLPI mRNA CTD PMID:32816093 fluticasone multiple interactions ISO RGD:1350976 6480464 [Fluticasone co-treated with Salmeterol Xinafoate] results in increased expression of SLPI mRNA, Salmeterol Xinafoate promotes the reaction [Fluticasone results in increased expression of SLPI mRNA] CTD PMID:15860753 , PMID:15862954 fluticasone increases expression ISO RGD:1350976 6480464 Fluticasone results in increased expression of SLPI mRNA CTD PMID:15860753 fulvestrant multiple interactions ISO RGD:1551752 6480464 fulvestrant inhibits the reaction [Genistein results in increased expression of SLPI mRNA] CTD PMID:22553218 furan increases expression EXP 6480464 furan results in increased expression of SLPI mRNA CTD PMID:27387713 genistein multiple interactions ISO RGD:1551752 6480464 fulvestrant inhibits the reaction [Genistein results in increased expression of SLPI mRNA] CTD PMID:22553218 genistein increases expression ISO RGD:1551752 6480464 Genistein results in increased expression of SLPI mRNA CTD PMID:21810550 more ... gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLPI mRNA CTD PMID:22061828 hydrogen peroxide increases expression ISO RGD:1551752 6480464 Hydrogen Peroxide results in increased expression of SLPI mRNA CTD PMID:14729362 , PMID:15003993 hydrogen peroxide affects expression ISO RGD:1350976 6480464 Hydrogen Peroxide affects the expression of SLPI mRNA CTD PMID:20044591 hydroxyzine increases expression ISO RGD:1350976 6480464 Hydroxyzine results in increased expression of SLPI mRNA CTD PMID:32816093 Iproniazid increases expression ISO RGD:1350976 6480464 Iproniazid results in increased expression of SLPI mRNA CTD PMID:32816093 irinotecan affects expression EXP 6480464 Irinotecan affects the expression of SLPI mRNA CTD PMID:20097248 iron atom decreases expression ISO RGD:1350976 6480464 Iron deficiency results in decreased expression of SLPI mRNA CTD PMID:20368581 iron(0) decreases expression ISO RGD:1350976 6480464 Iron deficiency results in decreased expression of SLPI mRNA CTD PMID:20368581 isoniazide increases expression ISO RGD:1350976 6480464 Isoniazid results in increased expression of SLPI mRNA CTD PMID:32816093 isoprenaline increases expression ISO RGD:1350976 6480464 Isoproterenol results in increased expression of SLPI mRNA CTD PMID:32816093 ketoconazole decreases expression ISO RGD:1350976 6480464 Ketoconazole results in decreased expression of SLPI mRNA CTD PMID:32816093 ketorolac tromethamine increases expression ISO RGD:1350976 6480464 Ketorolac Tromethamine results in increased expression of SLPI mRNA CTD PMID:32816093 levofloxacin decreases expression ISO RGD:1350976 6480464 Levofloxacin results in decreased expression of SLPI mRNA CTD PMID:32816093 lipopolysaccharide multiple interactions ISO RGD:1551752 6480464 (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of SLPI mRNA] CTD PMID:25890327 lipopolysaccharide increases expression ISO RGD:1551752 6480464 Lipopolysaccharides results in increased expression of SLPI mRNA CTD PMID:25890327 , PMID:27339419 loratadine increases expression ISO RGD:1350976 6480464 Loratadine results in increased expression of SLPI mRNA CTD PMID:32816093 lumiracoxib decreases expression ISO RGD:1350976 6480464 lumiracoxib results in decreased expression of SLPI mRNA CTD PMID:32816093 mebendazole increases expression ISO RGD:1350976 6480464 Mebendazole results in increased expression of SLPI mRNA CTD PMID:32816093 metaproterenol increases expression ISO RGD:1350976 6480464 Metaproterenol results in increased expression of SLPI mRNA CTD PMID:32816093 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of SLPI mRNA CTD PMID:31378766 minoxidil increases expression ISO RGD:1350976 6480464 Minoxidil results in increased expression of SLPI mRNA CTD PMID:32816093 monosodium L-glutamate increases expression ISO RGD:1551752 6480464 Sodium Glutamate results in increased expression of SLPI mRNA CTD PMID:22078008 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of SLPI mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions ISO RGD:1551752 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of SLPI mRNA CTD PMID:24535843 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of SLPI mRNA CTD PMID:28943392 N-nitrosodiethylamine increases expression ISO RGD:1551752 6480464 Diethylnitrosamine results in increased expression of SLPI mRNA CTD PMID:24535843 naphthalene increases expression ISO RGD:1551752 6480464 naphthalene results in increased expression of SLPI mRNA CTD PMID:18978301 nefazodone increases expression ISO RGD:1350976 6480464 nefazodone results in increased expression of SLPI mRNA CTD PMID:32816093 nickel subsulfide decreases expression EXP 6480464 nickel subsulfide results in decreased expression of SLPI mRNA CTD PMID:21086188 nimesulide increases expression ISO RGD:1350976 6480464 nimesulide results in increased expression of SLPI mRNA CTD PMID:32816093 nomifensine increases expression ISO RGD:1350976 6480464 Nomifensine results in increased expression of SLPI mRNA CTD PMID:32816093 orciprenaline increases expression ISO RGD:1350976 6480464 Metaproterenol results in increased expression of SLPI mRNA CTD PMID:32816093 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SLPI mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of SLPI mRNA CTD PMID:25729387 oxybutynin increases expression ISO RGD:1350976 6480464 oxybutynin results in increased expression of SLPI mRNA CTD PMID:32816093 oxycodone decreases expression EXP 6480464 Oxycodone results in decreased expression of SLPI mRNA CTD PMID:23439660 ozone decreases secretion ISO RGD:1350976 6480464 Ozone results in decreased secretion of SLPI protein CTD PMID:22496898 ozone multiple interactions ISO RGD:1350976 6480464 epigallocatechin gallate inhibits the reaction [Ozone results in decreased secretion of SLPI protein] CTD PMID:22496898 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of SLPI mRNA CTD PMID:17984051 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLPI mRNA CTD PMID:33387578 paraquat increases expression ISO RGD:1551752 6480464 Paraquat results in increased expression of SLPI protein CTD PMID:26345256 penbutolol increases expression ISO RGD:1350976 6480464 Penbutolol results in increased expression of SLPI mRNA CTD PMID:32816093 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of SLPI mRNA CTD PMID:16221955 phenobarbital multiple interactions ISO RGD:1551752 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of SLPI mRNA, NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SLPI mRNA] CTD PMID:19482888 , PMID:24535843 phenobarbital increases expression ISO RGD:1551752 6480464 Phenobarbital results in increased expression of SLPI mRNA CTD PMID:19482888 PhIP decreases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in decreased expression of SLPI mRNA CTD PMID:15215175 pirinixic acid decreases expression ISO RGD:1551752 6480464 pirinixic acid results in decreased expression of SLPI mRNA CTD PMID:17426115 pirinixic acid increases expression ISO RGD:1551752 6480464 pirinixic acid results in increased expression of SLPI mRNA CTD PMID:20813756 pirinixic acid multiple interactions ISO RGD:1551752 6480464 [pirinixic acid co-treated with PPARA] results in increased expression of SLPI mRNA CTD PMID:20813756 pirprofen increases expression ISO RGD:1350976 6480464 pirprofen results in increased expression of SLPI mRNA CTD PMID:32816093 primaquine increases expression ISO RGD:1350976 6480464 Primaquine results in increased expression of SLPI mRNA CTD PMID:32816093 primidone decreases expression ISO RGD:1350976 6480464 Primidone results in decreased expression of SLPI mRNA CTD PMID:32816093 procyclidine increases expression ISO RGD:1350976 6480464 Procyclidine results in increased expression of SLPI mRNA CTD PMID:32816093 progesterone affects expression ISO RGD:1551752 6480464 Progesterone affects the expression of SLPI mRNA CTD PMID:17251523 propanal decreases expression ISO RGD:1350976 6480464 propionaldehyde results in decreased expression of SLPI mRNA CTD PMID:26079696 protriptyline increases expression ISO RGD:1350976 6480464 Protriptyline results in increased expression of SLPI mRNA CTD PMID:32816093 rofecoxib increases expression ISO RGD:1350976 6480464 rofecoxib results in increased expression of SLPI mRNA CTD PMID:32816093 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of SLPI mRNA CTD PMID:28374803 Salmeterol xinafoate multiple interactions ISO RGD:1350976 6480464 [Fluticasone co-treated with Salmeterol Xinafoate] results in increased expression of SLPI mRNA, Salmeterol Xinafoate promotes the reaction [Fluticasone results in increased expression of SLPI mRNA] CTD PMID:15860753 , PMID:15862954 serpentine asbestos decreases expression ISO RGD:1350976 6480464 Asbestos, Serpentine results in decreased expression of SLPI mRNA CTD PMID:24160326 serpentine asbestos increases expression ISO RGD:1350976 6480464 Asbestos, Serpentine results in increased expression of SLPI mRNA CTD PMID:24160326 silicon dioxide decreases expression ISO RGD:1350976 6480464 Silicon Dioxide analog results in decreased expression of SLPI mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:1551752 6480464 Silicon Dioxide results in increased expression of SLPI mRNA, Silicon Dioxide results in increased expression of SLPI protein CTD PMID:26345256 silicon dioxide increases expression ISO RGD:1350976 6480464 Silicon Dioxide analog results in increased expression of SLPI mRNA CTD PMID:23806026 sodium arsenate multiple interactions ISO RGD:1350976 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SLPI mRNA CTD PMID:32525701 succimer multiple interactions ISO RGD:1551752 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLPI mRNA CTD PMID:21641980 temozolomide affects response to substance ISO RGD:1350976 6480464 SLPI mRNA affects the susceptibility to temozolomide CTD PMID:16365179 tert-butyl hydroperoxide decreases response to substance ISO RGD:1551752 6480464 SLPI protein results in decreased susceptibility to tert-Butylhydroperoxide CTD PMID:15003993 tert-butyl hydroperoxide increases expression ISO RGD:1551752 6480464 tert-Butylhydroperoxide results in increased expression of SLPI mRNA CTD PMID:14729362 more ... tetrachloromethane increases expression ISO RGD:1551752 6480464 Carbon Tetrachloride results in increased expression of SLPI mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane multiple interactions ISO RGD:1551752 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of SLPI mRNA CTD PMID:30517762 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of SLPI mRNA CTD PMID:28943392 tienilic acid increases expression ISO RGD:1350976 6480464 Ticrynafen results in increased expression of SLPI mRNA CTD PMID:32816093 titanium dioxide increases expression ISO RGD:1551752 6480464 titanium dioxide results in increased expression of SLPI mRNA CTD PMID:19464567 , PMID:23557971 tolcapone decreases expression ISO RGD:1350976 6480464 Tolcapone results in decreased expression of SLPI mRNA CTD PMID:32816093 tolterodine tartrate increases expression ISO RGD:1350976 6480464 Tolterodine Tartrate results in increased expression of SLPI mRNA CTD PMID:32816093 tolvaptan increases expression ISO RGD:1551752 6480464 tolvaptan results in increased expression of SLPI mRNA, tolvaptan results in increased expression of SLPI protein CTD PMID:28115652 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SLPI mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of SLPI mRNA CTD PMID:25729387 trazodone increases expression ISO RGD:1350976 6480464 Trazodone results in increased expression of SLPI mRNA CTD PMID:32816093 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of SLPI mRNA CTD PMID:17905399 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SLPI mRNA CTD PMID:33387578 Trihexyphenidyl increases expression ISO RGD:1350976 6480464 Trihexyphenidyl results in increased expression of SLPI mRNA CTD PMID:32816093 trimellitic anhydride affects expression ISO RGD:1551752 6480464 trimellitic anhydride affects the expression of SLPI mRNA CTD PMID:22302311 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of SLPI mRNA CTD PMID:30589522 triprolidine decreases expression ISO RGD:1350976 6480464 Triprolidine results in decreased expression of SLPI mRNA CTD PMID:32816093 triptonide increases expression ISO RGD:1551752 6480464 triptonide results in increased expression of SLPI mRNA CTD PMID:33045310 troglitazone decreases expression ISO RGD:1350976 6480464 Troglitazone results in decreased expression of SLPI mRNA CTD PMID:32816093 tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate increases expression ISO RGD:1350976 6480464 Atropine results in increased expression of SLPI mRNA CTD PMID:32816093 tungsten decreases expression ISO RGD:1551752 6480464 Tungsten results in decreased expression of SLPI mRNA CTD PMID:30912803 undecane decreases expression EXP 6480464 undecane results in decreased expression of SLPI protein CTD PMID:17337753 valproic acid decreases methylation ISO RGD:1350976 6480464 Valproic Acid results in decreased methylation of SLPI gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1350976 6480464 Valproic Acid results in increased expression of SLPI mRNA CTD PMID:32816093 zafirlukast increases expression ISO RGD:1350976 6480464 zafirlukast results in increased expression of SLPI mRNA CTD PMID:32816093 zoledronic acid increases expression ISO RGD:1350976 6480464 zoledronic acid results in increased expression of SLPI mRNA, zoledronic acid results in increased expression of SLPI protein CTD PMID:24714768 , PMID:28871336
